353 related articles for article (PubMed ID: 18465098)
41. Nodal protrusions, increased Schmidt-Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves.
Hoshi T; Suzuki A; Hayashi S; Tohyama K; Hayashi A; Yamaguchi Y; Takeuchi K; Baba H
Glia; 2007 Apr; 55(6):584-94. PubMed ID: 17299768
[TBL] [Abstract][Full Text] [Related]
42. The Role of Sulfatides in Axon-Glia Interactions.
Baba H; Ishibashi T
Adv Exp Med Biol; 2019; 1190():165-179. PubMed ID: 31760644
[TBL] [Abstract][Full Text] [Related]
43. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
[TBL] [Abstract][Full Text] [Related]
44. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
[TBL] [Abstract][Full Text] [Related]
45. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
46. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
Coetzee T; Dupree JL; Popko B
J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
[TBL] [Abstract][Full Text] [Related]
47. Galactolipids in the formation and function of the myelin sheath.
Dupree JL; Suzuki K; Popko B
Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
[TBL] [Abstract][Full Text] [Related]
48. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes.
Dyer CA; Benjamins JA
J Neurosci Res; 1991 Dec; 30(4):699-711. PubMed ID: 1787543
[TBL] [Abstract][Full Text] [Related]
49. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells.
Jeon SB; Yoon HJ; Park SH; Kim IH; Park EJ
J Immunol; 2008 Dec; 181(11):8077-87. PubMed ID: 19018000
[TBL] [Abstract][Full Text] [Related]
50. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
51. Role of sulfatide in normal and pathological cells and tissues.
Takahashi T; Suzuki T
J Lipid Res; 2012 Aug; 53(8):1437-50. PubMed ID: 22619219
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and turnover of cerebroside sulfate of myelin in adult and developing rat brain.
Jungalwala FB
J Lipid Res; 1974 Mar; 15(2):114-23. PubMed ID: 4832754
[TBL] [Abstract][Full Text] [Related]
53. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
Hirahara Y; Bansal R; Honke K; Ikenaka K; Wada Y
Glia; 2004 Feb; 45(3):269-77. PubMed ID: 14730700
[TBL] [Abstract][Full Text] [Related]
54. Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes.
Boggs JM; Gao W; Zhao J; Park HJ; Liu Y; Basu A
FEBS Lett; 2010 May; 584(9):1771-8. PubMed ID: 19941861
[TBL] [Abstract][Full Text] [Related]
55. Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy.
Frati G; Luciani M; Meneghini V; De Cicco S; Ståhlman M; Blomqvist M; Grossi S; Filocamo M; Morena F; Menegon A; Martino S; Gritti A
Cell Death Dis; 2018 Jun; 9(6):698. PubMed ID: 29899471
[TBL] [Abstract][Full Text] [Related]
56. Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice.
van Zyl R; Gieselmann V; Eckhardt M
J Neurochem; 2010 Jan; 112(1):282-95. PubMed ID: 19860853
[TBL] [Abstract][Full Text] [Related]
57. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
[TBL] [Abstract][Full Text] [Related]
58. Brain galactolipid content in a patient with pseudoarylsulfatase A deficiency and coincidental diffuse disseminated sclerosis, and in patients with metachromatic, adreno-, and other leukodystrophies.
Harzer K; Kustermann-Kuhn B
J Neurochem; 1987 Jan; 48(1):62-6. PubMed ID: 2878976
[TBL] [Abstract][Full Text] [Related]
59. Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.
Harzer K; Recke AS
Humangenetik; 1975 Oct; 29(4):299-307. PubMed ID: 1176145
[TBL] [Abstract][Full Text] [Related]
60. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain.
Rosengren B; Fredman P; Månsson JE; Svennerholm L
J Neurochem; 1989 Apr; 52(4):1035-41. PubMed ID: 2926387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
